Prehospital Tirofiban Increases the Rate of Disrupted Myocardial Infarction in Patients with ST-Segment Elevation Myocardial Infarction: Insights From the On-TIME 2 Trial.
Sem A O F RikkenEnrico FabrisTobias RosenqvistEvangelos GiannitsisJurriën M Ten BergChristian W HammArnoud W J van 't HofPublished in: European heart journal. Acute cardiovascular care (2024)
Among STEMI patients undergoing primary PCI, the use of prehospital tirofiban was independently associated with a higher rate of disrupted MI. These results, highlighting a potential benefit, underscore the need for future research focusing on innovative pretreatment approaches which may increase the rate of disrupted MI.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- patients undergoing
- cardiac arrest
- st elevation myocardial infarction
- resting state
- acute myocardial infarction
- coronary artery disease
- acute coronary syndrome
- antiplatelet therapy
- coronary artery bypass grafting
- clinical trial
- heart failure
- functional connectivity
- left ventricular
- study protocol
- trauma patients
- atrial fibrillation
- current status
- risk assessment
- phase ii
- climate change